AdaptHealth (NASDAQ:AHCO) Trading Down 3.9% - Time to Sell?

AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report)'s stock price fell 3.9% on Wednesday . The stock traded as low as $9.31 and last traded at $9.16. 39,155 shares were traded during trading, a decline of 97% from the average session volume of 1,324,900 shares. The stock had previously closed at $9.53.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on AHCO. Truist Financial reduced their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, May 12th. Royal Bank Of Canada reduced their price objective on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a research report on Thursday, May 8th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, AdaptHealth presently has a consensus rating of "Buy" and an average price target of $13.40.

AdaptHealth Stock Performance

The stock has a market cap of $1.24 billion, a price-to-earnings ratio of 12.63, a PEG ratio of 1.07 and a beta of 1.63. The stock's 50 day moving average is $8.93 and its two-hundred day moving average is $9.42. The company has a current ratio of 1.29, a quick ratio of 1.07 and a debt-to-equity ratio of 1.25.

Institutional Trading of AdaptHealth

A number of large investors have recently bought and sold shares of AHCO. Reinhart Partners LLC. raised its position in AdaptHealth by 1.1% during the 2nd quarter. Reinhart Partners LLC. now owns 7,312,626 shares of the company's stock worth $68,958,000 after buying an additional 76,364 shares during the last quarter. Segall Bryant & Hamill LLC grew its stake in AdaptHealth by 29.8% in the 4th quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company's stock valued at $45,734,000 after acquiring an additional 1,102,173 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in AdaptHealth by 17.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,379,715 shares of the company's stock valued at $32,174,000 after acquiring an additional 505,180 shares during the last quarter. Palisade Capital Management LP grew its stake in AdaptHealth by 12.3% in the 1st quarter. Palisade Capital Management LP now owns 2,711,142 shares of the company's stock valued at $29,389,000 after acquiring an additional 297,268 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in AdaptHealth by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 2,467,769 shares of the company's stock valued at $23,499,000 after acquiring an additional 16,596 shares during the last quarter. Institutional investors and hedge funds own 82.67% of the company's stock.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.